Tag: gastroparesis market trends

  • Global Gastroparesis Market Report 2024: Size, Drivers, And Top Segments

    Global Gastroparesis Market Report 2024: Size, Drivers, And Top Segments

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How is the Gastroparesis Market Expected to Expand from 2024 to 2033?

    In the past few years, the size of the gastroparesis market has significantly expanded. It is expected to increase from $6.44 billion in 2023 to $6.8 billion in 2024, with a compound annual growth rate (CAGR) of 5.6%. The past growth can be attributed to factors such as an aging population, a rising prevalence of diabetes, increased comprehension of gastrointestinal disorders, development in treatment protocols, and heightened awareness about gastroparesis.

    The market size of gastroparesis is projected to witness consistent growth in the coming years, potentially reaching $8.19 billion by 2028 with a compound annual growth rate (CAGR) of 4.8%. The expected growth during this period can be linked to the advent of advanced therapeutic alternatives, the proliferation of personalized treatment strategies, the implementation of digital health solutions, the escalation of healthcare facilities, and a heightened emphasis on early diagnosis. Future trends encompassing this period may involve breakthroughs in gastric electrical stimulation therapy, expanding stem cell research, the incorporation of less invasive surgical procedures, the rise of wearable health tracking equipment, and a spotlight on care models centered on the patient.

    Claim Your Free Sample of the Global Gastroparesis Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

    What Influences Are Propelling the gastroparesis Market Forward?

    The uptick in gastroparesis incidences is predicted to boost the development of the gastroparesis market. Gastroparesis, a health issue that halts or slows the transition of food from the stomach to the small intestinal tract, is usually caused by hypothyroidism, autoimmune disorders, vagus nerve damage, or viral stomach infections. Medication for gastroparesis works by tensing and contracting the stomach wall muscles, thereby enhancing gastric emptying. An online Netherlands-based research articles publisher, Practice Update, in a study published in 2021, stated that the total prevalence rate of gastroparesis in the US was 267.7 out of 100,000 people. The confirmed gastroparesis prevalence rate was 21.5 out of 100,000 people. Consequently, the rising prevalence of gastroparesis is fueling the expansion of the gastroparesis treatment market.

    What Key Segments Exist Within the Gastroparesis Market?

    1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies

    2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types

    3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis

    4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

    5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

    What Trends Are Coming to the Forefront in the Gastroparesis Market?

    In the gastroparesis market, leading companies are focusing on the creation of cutting-edge devices to enhance their profitability. These devices for gastroparesis treatment are specially designed medical tools or equipment used to control or lessen the symptoms related to gastroparesis, a disorder marked by slow stomach emptying. For example, in 2022, Enterra Medical Inc., an American medical device firm, introduced an enterra therapy for managing gastroparesis. The Enterra Therapy system operates through an implanted neurostimulator that generates soft electrical pulses, providing potential relief for chronic nausea and vomiting symptoms associated with gastroparesis. This therapeutic approach is intended for individuals between the ages of 18 and 70 who suffer from chronic, unmanageable nausea and vomiting related to diabetic or idiopathic gastroparesis.

    Order Now for Fast Delivery of Your Gastroparesis Market Report!

    https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

    What Regions Are Leading the Charge in the Gastroparesis Market?

    North America was the largest region in the gastroparesis market in 2023. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Gastroparesis Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the gastroparesis market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Gastroparesis Market Include

    1. Gastroparesis Market Executive Summary

    2. Gastroparesis Market Segments

    3. Gastroparesis Market Size And Template Market Growth Rate

    4. Key Gastroparesis Market Trends

    5. Major Gastroparesis Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Gastroparesis Market

    26. Top Gastroparesis Companies

    27. Gastroparesis Market Opportunities And Strategies

    28. Gastroparesis Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Global Gastroparesis Market Key Insights 2024-2033

    Global Gastroparesis Market Key Insights 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Gastroparesis Global Market Report 2024, the gastroparesis market is expected to show promising growth in the forecast period.

    The gastroparesis market is witnessing robust growth, with a trajectory set to continue over the coming years. Factors contributing to this growth include:

    • Aging Population: As demographics shift, the incidence of gastroparesis increases, driving demand for treatment options.
    • Prevalence of Diabetes: With diabetes becoming more prevalent worldwide, the risk of developing gastroparesis rises, further fueling market expansion.
    • Improved Understanding of Gastrointestinal Disorders: Advances in medical research and diagnostics enhance the identification and management of gastroparesis cases.
    • Evolving Treatment Protocols: The development of new therapeutic approaches and protocols improves patient outcomes and drives market growth.
    • Growing Awareness: Increased awareness among both healthcare professionals and the general population leads to earlier diagnosis and intervention, boosting market demand.

    View More On The Gastroparesis Market Report 2024 – https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

    New Devices Transforming Gastroparesis Management

    Innovative devices play a crucial role in reshaping gastroparesis management, offering novel solutions to address patient needs. Key developments include:

    • Enterra Therapy: Introduced by Enterra Medical Inc. in 2022, this neurostimulation system provides targeted relief for chronic nausea and vomiting associated with gastroparesis.
    • Segment Analysis: The gastroparesis market is segmented based on various parameters, including treatment modality, gastroparesis type, patient demographics, distribution channels, and end-users.
    • Market Dynamics: North America emerges as a dominant region in the gastroparesis market, reflecting significant growth opportunities and market presence.

    Key Market Players and Competitive Landscape

    A multitude of companies are actively engaged in the gastroparesis market, driving innovation and competition. Major players include:

    • Pfizer Inc.
    • GlaxoSmithKline plc.
    • Abbott Laboratories Inc.
    • AstraZeneca Plc.
    • Medtronic Plc.
    • Takeda Pharmaceutical Company Limited
    • Novo Nordisk AS
    • Johnson And Johnson Services Inc.
    • Teva Pharmaceutical Industries Ltd.
    • AbbVie Inc.

    Future Trends and Forecast

    The gastroparesis market is poised for continued expansion, with a projected CAGR of 4.8% through 2028. Key trends shaping the market include:

    • Advancements in Gastric Electrical Stimulation Therapy: Ongoing research and development efforts aim to enhance the efficacy and accessibility of gastric electrical stimulation for gastroparesis management.
    • Stem Cell Therapy: Growing interest in regenerative medicine approaches, such as stem cell therapy, holds promise for addressing gastroparesis and its associated symptoms.
    • Minimally Invasive Surgical Interventions: The adoption of minimally invasive techniques minimizes patient discomfort and accelerates recovery, driving demand for surgical interventions.
    • Wearable Health Monitoring Devices: The integration of wearable technologies enables continuous monitoring of gastrointestinal function, facilitating personalized treatment approaches.
    • Patient-Centric Care Models: A shift towards patient-centric care emphasizes individualized treatment plans and holistic management strategies, improving patient outcomes and satisfaction.

    Conclusion

    As the prevalence of gastroparesis continues to rise, the market for its treatment and management is experiencing significant growth. With a diverse range of therapeutic options and innovative devices entering the market, patients have access to more effective and tailored interventions than ever before. Looking ahead, continued advancements in medical technology, coupled with a focus on personalized care and early intervention, are poised to drive further expansion and improvement in gastroparesis treatment outcomes.

    Request A Sample Of The Global Gastroparesis Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12189&type=smp